Litcius/Paper detail

High-performance pyrite nano-catalyst driven photothermal/chemodynamic synergistic therapy for Osteosarcoma

Meirong Li, Minghua Wang, Junfeng Huang, Shiqi Tang, Jingyu Yang, Zhourui Xu, Gaixia Xu, Xin Chen, Jia Liu, Chengbin Yang

2024Journal of Nanobiotechnology16 citationsDOIOpen Access PDF

Abstract

Abstract Osteosarcoma (OS) is an aggressive bone tumor with strong invasiveness, rapid metastasis, and dreadful mortality. Chemotherapy is a commonly used approach for OS treatment but is limited by the development of drug resistance and long-term adverse effects. To date, OS still lacks the curative treatment. Herein, we fabricated pyrite-based nanoparticles (FeS 2 @CP NPs) as synergetic therapeutic platform by integrating photothermal therapy (PTT) and chemo-dynamic therapy (CDT) into one system. The synthetic FeS 2 @CP NPs showed superior Fenton reaction catalytic activity. FeS 2 @CP NPs-based CDT efficaciously eradicated the tumor cells by initiating dual-effect of killing of apoptosis and ferroptosis. Furthermore, the generated heat from FeS 2 @CP under near-infrared region II (NIR-II) laser irradiation could not only inhibit tumor’s growth, but also promote tumor cell apoptosis and ferroptosis by accelerating •OH production and GSH depletion. Finally, the photothermal/NIR II-enhanced CDT synergistic therapy showed excellent osteosarcoma treatment effects both in vitro and in vivo with negligible side effects. Overall, this work provided a high-performance and multifunctional Fenton catalyst for osteosarcoma synergistic therapy, which provided a pathway for the clinical application of PTT augmented CDT.

Topics & Concepts

Photothermal therapyOsteosarcomaIn vivoApoptosisCancer researchChemistryIn vitroRadiation therapyNanotechnologyMaterials scienceMedicineBiologyBiochemistryInternal medicineBiotechnologyNanoplatforms for cancer theranosticsExtracellular vesicles in diseaseAdvanced Nanomaterials in Catalysis